Modafinil: mischaracterization

J Clin Psychiatry. 2007 Jun;68(6):970-1; author reply 971-2. doi: 10.4088/jcp.v68n0624b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Benzhydryl Compounds / adverse effects
  • Benzhydryl Compounds / pharmacology*
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / pharmacology*
  • Drug Industry
  • Drug Labeling*
  • Humans
  • Modafinil
  • Substance-Related Disorders*
  • United States
  • United States Food and Drug Administration

Substances

  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • Modafinil